2,842
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Anti-allergic actions of a Chinese patent medicine, huoxiangzhengqi oral liquid, in RBL-2H3 cells and in mice

, , , , , , , , , , & show all
Pages 670-680 | Received 02 Feb 2021, Accepted 04 May 2021, Published online: 02 Jun 2021

Figures & data

Table 1. Constituents of HXZQ-OL.

Table 2. Forward and reverse primers sequences of genes.

Figure 1. Effects of HXZQ-OL on degranulation (A) and cell viability (B) in IgE/Ag-mediated RBL-2H3 cells. The data were expressed as the mean ± SD values of five independent experiments. *p < 0.05 and **p < 0.01.

Figure 1. Effects of HXZQ-OL on degranulation (A) and cell viability (B) in IgE/Ag-mediated RBL-2H3 cells. The data were expressed as the mean ± SD values of five independent experiments. *p < 0.05 and **p < 0.01.

Figure 2. HXZQ-OL inhibited the release of proinflammatory mediators: IL-4 (A), TNF-α (B), LTC4 (C) and PGD2 (D) in IgE/Ag-mediated RBL-2H3 cells. IgE-sensitized RBL-2H3 cells were incubated with HXZQ-OL (43.97, 439.7 and 4397 μg/mL) for 30 min, followed by DNP-BSA challenge for 4 h. The amounts of IL-4, TNF-α, LTC4 and PGD2 were determined using ELISA kits following the manufacturers’ instructions. The data were expressed as the mean ± SD values of three independent experiments. *p < 0.05 and **p < 0.01.

Figure 2. HXZQ-OL inhibited the release of proinflammatory mediators: IL-4 (A), TNF-α (B), LTC4 (C) and PGD2 (D) in IgE/Ag-mediated RBL-2H3 cells. IgE-sensitized RBL-2H3 cells were incubated with HXZQ-OL (43.97, 439.7 and 4397 μg/mL) for 30 min, followed by DNP-BSA challenge for 4 h. The amounts of IL-4, TNF-α, LTC4 and PGD2 were determined using ELISA kits following the manufacturers’ instructions. The data were expressed as the mean ± SD values of three independent experiments. *p < 0.05 and **p < 0.01.

Figure 3. HXZQ-OL reduced the levels of IL-4 mRNA (A) and TNF-α mRNA (B) in IgE/Ag-mediated RBL-2H3 cells. IgE-sensitized RBL-2H3 cells were incubated with HXZQ-OL (43.97, 439.7 and 4397 μg/mL) for 30 min, followed by DNP-BSA challenge for 4 h. The gene expression of IL-4 and TNF-α were measured by RT-qPCR. The data were expressed as the mean ± SD values of three independent experiments. *p < 0.05 and **p < 0.01.

Figure 3. HXZQ-OL reduced the levels of IL-4 mRNA (A) and TNF-α mRNA (B) in IgE/Ag-mediated RBL-2H3 cells. IgE-sensitized RBL-2H3 cells were incubated with HXZQ-OL (43.97, 439.7 and 4397 μg/mL) for 30 min, followed by DNP-BSA challenge for 4 h. The gene expression of IL-4 and TNF-α were measured by RT-qPCR. The data were expressed as the mean ± SD values of three independent experiments. *p < 0.05 and **p < 0.01.

Figure 4. HXZQ-OL inhibited the intracellular Ca2+ concentration in IgE/Ag-mediated RBL-2H3 cells. IgE-sensitized RBL-2H3 cells were incubated with HXZQ-OL for 30 min, followed by DNP-BSA challenge for 10 min. The intracellular Ca2+ concentration was determined using flow cytometry with Fluo 3/AM probe. The data were expressed as the mean ± SD values of three independent experiments. *p < 0.05 and **p < 0.01.

Figure 4. HXZQ-OL inhibited the intracellular Ca2+ concentration in IgE/Ag-mediated RBL-2H3 cells. IgE-sensitized RBL-2H3 cells were incubated with HXZQ-OL for 30 min, followed by DNP-BSA challenge for 10 min. The intracellular Ca2+ concentration was determined using flow cytometry with Fluo 3/AM probe. The data were expressed as the mean ± SD values of three independent experiments. *p < 0.05 and **p < 0.01.

Figure 5. Inhibitory effects of HXZQ-OL on the phosphorylation of FcεRI-induced degranulation signalling cascades (A, B, C) and MAPKs (D) in IgE/Ag-mediated RBL-2H3 cells. IgE-sensitized RBL-2H3 cells were incubated with HXZQ-OL for 30 min, followed by DNP-BSA challenge for 10 min. The expression levels of p-Fyn, p-Lyn, p-Syk, p-PLCγ1, p-PLCγ2, p-PKCδ, p-Gabs, p-PI3K, p-Akt, p-ERK1/2, p-p38 and p-JNK1/2 were normalized to total proteins, respectively. The data were expressed as the mean ± SD values of three independent experiments. *p < 0.05 and **p < 0.01.

Figure 5. Inhibitory effects of HXZQ-OL on the phosphorylation of FcεRI-induced degranulation signalling cascades (A, B, C) and MAPKs (D) in IgE/Ag-mediated RBL-2H3 cells. IgE-sensitized RBL-2H3 cells were incubated with HXZQ-OL for 30 min, followed by DNP-BSA challenge for 10 min. The expression levels of p-Fyn, p-Lyn, p-Syk, p-PLCγ1, p-PLCγ2, p-PKCδ, p-Gabs, p-PI3K, p-Akt, p-ERK1/2, p-p38 and p-JNK1/2 were normalized to total proteins, respectively. The data were expressed as the mean ± SD values of three independent experiments. *p < 0.05 and **p < 0.01.

Figure 6. Inhibitory effects of HXZQ-OL on the activations of PI3K/NF-κB (A) and eicosanoid cascades (B) in IgE/Ag-mediated RBL-2H3 cells. IgE-sensitized RBL-2H3 cells were preincubated with HXZQ-OL for 30 min, followed by DNP-BSA challenge for 4 h. P-IKKα/β and p-cPLA2 were normalized to total proteins, respectively. The endogenous reference protein used for p-IκB, IκB, 5-LO, COX-2 and cytosolic NF-κB p65 was β-actin whereas for nuclear NF-κB p65 was Lamin B. The data were expressed as the mean ± SD values of three independent experiments. *p < 0.05 and **p < 0.01.

Figure 6. Inhibitory effects of HXZQ-OL on the activations of PI3K/NF-κB (A) and eicosanoid cascades (B) in IgE/Ag-mediated RBL-2H3 cells. IgE-sensitized RBL-2H3 cells were preincubated with HXZQ-OL for 30 min, followed by DNP-BSA challenge for 4 h. P-IKKα/β and p-cPLA2 were normalized to total proteins, respectively. The endogenous reference protein used for p-IκB, IκB, 5-LO, COX-2 and cytosolic NF-κB p65 was β-actin whereas for nuclear NF-κB p65 was Lamin B. The data were expressed as the mean ± SD values of three independent experiments. *p < 0.05 and **p < 0.01.

Figure 7. HXZQ-OL inhibited IgE/Ag-mediated PCA in mice. (A) Experimental schedule. (B) Evans blue exudation. BALB/c mice were orally administrated with HXZQ-OL (263.8, 527.6 and 1055 mg/kg/d) or dexamethasone (DEX, 5 mg/kg/d) for seven consecutive days. One hour after the administration with HXZQ-OL, the ears of mice were intradermally injected with 100 ng anti-DNP-IgE on the sixth day. Twenty-four hour after ears sensitisation with IgE, mice were intravenously injected with 100 µg DNP-BSA containing 0.5% Evans blue for 30 min. After 30 min, Evans blue was extracted, and the absorbance was measured at 630 nm. The data were expressed as the mean ± SD values of five independent experiments. *p < 0.05 and **p < 0.01.

Figure 7. HXZQ-OL inhibited IgE/Ag-mediated PCA in mice. (A) Experimental schedule. (B) Evans blue exudation. BALB/c mice were orally administrated with HXZQ-OL (263.8, 527.6 and 1055 mg/kg/d) or dexamethasone (DEX, 5 mg/kg/d) for seven consecutive days. One hour after the administration with HXZQ-OL, the ears of mice were intradermally injected with 100 ng anti-DNP-IgE on the sixth day. Twenty-four hour after ears sensitisation with IgE, mice were intravenously injected with 100 µg DNP-BSA containing 0.5% Evans blue for 30 min. After 30 min, Evans blue was extracted, and the absorbance was measured at 630 nm. The data were expressed as the mean ± SD values of five independent experiments. *p < 0.05 and **p < 0.01.

Figure 8. HPLC chromatograms of HXZQ-OL (A) Contour plot (190–400 nm) (B) 276 nm. 5-HMF (1), liquiritin (2), narirutin (3), hesperidin (4), isoliquiritin (5), glycyrrhizin (6), honokiol (7) and magnolol (8) were identified. HPLC analysis was described in the materials and methods.

Figure 8. HPLC chromatograms of HXZQ-OL (A) Contour plot (190–400 nm) (B) 276 nm. 5-HMF (1), liquiritin (2), narirutin (3), hesperidin (4), isoliquiritin (5), glycyrrhizin (6), honokiol (7) and magnolol (8) were identified. HPLC analysis was described in the materials and methods.